_id
691844593c536f8df2317734
Ticker
XLO
Name
Xilio Development Inc
Exchange
NASDAQ
Address
828 Winter Street, Waltham, MA, United States, 02451
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://xiliotx.com
Description
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company's checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
Last Close
0.7103
Volume
575962
Current Price
0.6811
Change
-4.110939039842321
Last Updated
2025-12-05T14:04:47.849Z
Image
https://logo.clearbit.com/xiliotx.com
Ipo Date
2021-10-22T00:00:00.000Z
Market Cap
38902744
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9976666666666666
Sentiment Sources
3
Rating
5
Target Price
2
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
19066000
Cost Of Revenue
340000
Gross Profit
18726000
Operating Expenses
20655000
Operating Income
-1929000
Interest Expense
-
Pretax Income
-16286999
Net Income
-16286999
Eps
-0.11302028219071222
Dividends Per Share
-
Shares Outstanding
52500328
Income Tax Expense
-
EBITDA
-15946999
Operating Margin
-10.117486625406483
Total Other Income Expense Net
-14357999
Cash
103764000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
124089000
Property Plant Equipment
7804000
Total Assets
133694000
Payables
2300000
Short Term Debt
1303000
Long Term Debt
-
Total Liabilities
141789000
Equity
-8095000
Depreciation
340000
Change In Working Capital
-18051000
Cash From Operations
-17495000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-285000
Net Change In Cash
-17787000
PE
-
PB
-12.1249151915874
ROE
201.19825818406426
ROA
-12.182296138944155
FCF
-17495000
Fcf Percent
-0.9176020140564355
Piotroski FScore
0
Health Score
30
Deep Value Investing Score
2.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
4.5
Growth Investing Score
4.5
Momentum Investing Score
2.5
Net Net Investing Score
2
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
19066000
Quarters > 0 > income Statement > cost Of Revenue
340000
Quarters > 0 > income Statement > gross Profit
18726000
Quarters > 0 > income Statement > operating Expenses
20655000
Quarters > 0 > income Statement > operating Income
-1929000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-16286999
Quarters > 0 > income Statement > net Income
-16286999
Quarters > 0 > income Statement > eps
-0.11302028219071222
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
144106869
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-15946999
Quarters > 0 > income Statement > operating Margin
-10.117486625406483
Quarters > 0 > income Statement > total Other Income Expense Net
-14357999
Quarters > 0 > balance Sheet > cash
103764000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
124089000
Quarters > 0 > balance Sheet > property Plant Equipment
7804000
Quarters > 0 > balance Sheet > total Assets
133694000
Quarters > 0 > balance Sheet > payables
2300000
Quarters > 0 > balance Sheet > short Term Debt
1303000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
141789000
Quarters > 0 > balance Sheet > equity
-8095000
Quarters > 0 > cash Flow > net Income
-16286999
Quarters > 0 > cash Flow > depreciation
340000
Quarters > 0 > cash Flow > change In Working Capital
-18051000
Quarters > 0 > cash Flow > cash From Operations
-17495000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-285000
Quarters > 0 > cash Flow > net Change In Cash
-17787000
Quarters > 0 > ratios > PE
-0.11302028219071222
Quarters > 0 > ratios > PB
-12.1249151915874
Quarters > 0 > ratios > ROE
201.19825818406426
Quarters > 0 > ratios > ROA
-12.182296138944155
Quarters > 0 > ratios > FCF
-17495000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-0.9176020140564355
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
8084000
Quarters > 1 > income Statement > cost Of Revenue
15330000
Quarters > 1 > income Statement > gross Profit
-7246000
Quarters > 1 > income Statement > operating Expenses
7120000
Quarters > 1 > income Statement > operating Income
-14366000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-15844000
Quarters > 1 > income Statement > net Income
-15844000
Quarters > 1 > income Statement > eps
-0.16427560843562922
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
96447672
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-13985000
Quarters > 1 > income Statement > operating Margin
-177.70905492330527
Quarters > 1 > income Statement > total Other Income Expense Net
-1478000
Quarters > 1 > balance Sheet > cash
121551000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
123716000
Quarters > 1 > balance Sheet > property Plant Equipment
8303000
Quarters > 1 > balance Sheet > total Assets
133813000
Quarters > 1 > balance Sheet > payables
4097000
Quarters > 1 > balance Sheet > short Term Debt
1264000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
126744000
Quarters > 1 > balance Sheet > equity
7069000
Quarters > 1 > cash Flow > net Income
-15844000
Quarters > 1 > cash Flow > depreciation
381000
Quarters > 1 > cash Flow > change In Working Capital
-2699000
Quarters > 1 > cash Flow > cash From Operations
-14477000
Quarters > 1 > cash Flow > capital Expenditures
401000
Quarters > 1 > cash Flow > cash From Investing
-401000
Quarters > 1 > cash Flow > cash From Financing
47362000
Quarters > 1 > cash Flow > net Change In Cash
32484000
Quarters > 1 > ratios > PE
-0.16427560843562922
Quarters > 1 > ratios > PB
9.29275843813835
Quarters > 1 > ratios > ROE
-224.13354081199603
Quarters > 1 > ratios > ROA
-11.840404146084461
Quarters > 1 > ratios > FCF
-14878000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.8404255319148937
Quarters > 1 > health Score
9
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
2930000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
2930000
Quarters > 2 > income Statement > operating Expenses
16781000
Quarters > 2 > income Statement > operating Income
-13851000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-13265000
Quarters > 2 > income Statement > net Income
-13265000
Quarters > 2 > income Statement > eps
-0.1775761092676871
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
74700364
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-13354000
Quarters > 2 > income Statement > operating Margin
-472.73037542662115
Quarters > 2 > income Statement > total Other Income Expense Net
586000
Quarters > 2 > balance Sheet > cash
89073000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
93200000
Quarters > 2 > balance Sheet > property Plant Equipment
8728000
Quarters > 2 > balance Sheet > total Assets
103716000
Quarters > 2 > balance Sheet > payables
2275000
Quarters > 2 > balance Sheet > short Term Debt
1226000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
93016000
Quarters > 2 > balance Sheet > equity
10700000
Quarters > 2 > cash Flow > net Income
-13265000
Quarters > 2 > cash Flow > depreciation
497000
Quarters > 2 > cash Flow > change In Working Capital
40211000
Quarters > 2 > cash Flow > cash From Operations
28978000
Quarters > 2 > cash Flow > capital Expenditures
22000
Quarters > 2 > cash Flow > cash From Investing
-22000
Quarters > 2 > cash Flow > cash From Financing
4832000
Quarters > 2 > cash Flow > net Change In Cash
33788000
Quarters > 2 > ratios > PE
-0.1775761092676871
Quarters > 2 > ratios > PB
4.754992329009346
Quarters > 2 > ratios > ROE
-123.97196261682244
Quarters > 2 > ratios > ROA
-12.789733503027497
Quarters > 2 > ratios > FCF
28956000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
9.88259385665529
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1724000
Quarters > 3 > income Statement > cost Of Revenue
444000
Quarters > 3 > income Statement > gross Profit
1724000
Quarters > 3 > income Statement > operating Expenses
15353000
Quarters > 3 > income Statement > operating Income
-13629000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-13093000
Quarters > 3 > income Statement > net Income
-13093000
Quarters > 3 > income Statement > eps
-0.2024398540416847
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
64676000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-13254000
Quarters > 3 > income Statement > operating Margin
-790.5452436194896
Quarters > 3 > income Statement > total Other Income Expense Net
536000
Quarters > 3 > balance Sheet > cash
55291000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
60234000
Quarters > 3 > balance Sheet > property Plant Equipment
9059000
Quarters > 3 > balance Sheet > total Assets
71075000
Quarters > 3 > balance Sheet > payables
2574000
Quarters > 3 > balance Sheet > short Term Debt
1188000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
53477000
Quarters > 3 > balance Sheet > equity
17598000
Quarters > 3 > cash Flow > net Income
-13093000
Quarters > 3 > cash Flow > depreciation
375000
Quarters > 3 > cash Flow > change In Working Capital
-2957000
Quarters > 3 > cash Flow > cash From Operations
-14157000
Quarters > 3 > cash Flow > capital Expenditures
6000
Quarters > 3 > cash Flow > cash From Investing
-6000
Quarters > 3 > cash Flow > cash From Financing
8202000
Quarters > 3 > cash Flow > net Change In Cash
-5961000
Quarters > 3 > ratios > PE
-0.2024398540416847
Quarters > 3 > ratios > PB
2.5031721559268103
Quarters > 3 > ratios > ROE
-74.40050005682464
Quarters > 3 > ratios > ROA
-18.421385860007035
Quarters > 3 > ratios > FCF
-14163000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-8.215197215777263
Quarters > 3 > health Score
16
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
6344000
Annuals > 0 > income Statement > cost Of Revenue
1644000
Annuals > 0 > income Statement > gross Profit
6344000
Annuals > 0 > income Statement > operating Expenses
66926000
Annuals > 0 > income Statement > operating Income
-60582000
Annuals > 0 > income Statement > interest Expense
100000
Annuals > 0 > income Statement > pretax Income
-58241000
Annuals > 0 > income Statement > net Income
-58241000
Annuals > 0 > income Statement > eps
-1.0883844167555699
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
53511424
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-58001000
Annuals > 0 > income Statement > operating Margin
-954.9495586380832
Annuals > 0 > income Statement > total Other Income Expense Net
2341000
Annuals > 0 > balance Sheet > cash
55291000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
60234000
Annuals > 0 > balance Sheet > property Plant Equipment
9059000
Annuals > 0 > balance Sheet > total Assets
71075000
Annuals > 0 > balance Sheet > payables
2574000
Annuals > 0 > balance Sheet > short Term Debt
1188000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
53477000
Annuals > 0 > balance Sheet > equity
17598000
Annuals > 0 > cash Flow > net Income
-58241000
Annuals > 0 > cash Flow > depreciation
1644000
Annuals > 0 > cash Flow > change In Working Capital
31782000
Annuals > 0 > cash Flow > cash From Operations
-18378000
Annuals > 0 > cash Flow > capital Expenditures
36000
Annuals > 0 > cash Flow > cash From Investing
-36000
Annuals > 0 > cash Flow > cash From Financing
29196000
Annuals > 0 > cash Flow > net Change In Cash
10782000
Annuals > 0 > ratios > PE
-1.0883844167555699
Annuals > 0 > ratios > PB
2.2532086137061027
Annuals > 0 > ratios > ROE
-330.9523809523809
Annuals > 0 > ratios > ROA
-81.94301793879704
Annuals > 0 > ratios > FCF
-18414000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-2.9025851197982346
Annuals > 0 > health Score
16
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1900000
Annuals > 1 > income Statement > gross Profit
-1900000
Annuals > 1 > income Statement > operating Expenses
79133000
Annuals > 1 > income Statement > operating Income
-79133000
Annuals > 1 > income Statement > interest Expense
127800
Annuals > 1 > income Statement > pretax Income
-76404000
Annuals > 1 > income Statement > net Income
-76404000
Annuals > 1 > income Statement > eps
-2.778720638525301
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
27496107
Annuals > 1 > income Statement > income Tax Expense
-927000
Annuals > 1 > income Statement > EBITDA
-77233000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
2729000
Annuals > 1 > balance Sheet > cash
44704000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
48127000
Annuals > 1 > balance Sheet > property Plant Equipment
11201000
Annuals > 1 > balance Sheet > total Assets
60926000
Annuals > 1 > balance Sheet > payables
1050000
Annuals > 1 > balance Sheet > short Term Debt
3315000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
24099000
Annuals > 1 > balance Sheet > equity
36827000
Annuals > 1 > cash Flow > net Income
-76404000
Annuals > 1 > cash Flow > depreciation
1900000
Annuals > 1 > cash Flow > change In Working Capital
-1658000
Annuals > 1 > cash Flow > cash From Operations
-68620000
Annuals > 1 > cash Flow > capital Expenditures
486000
Annuals > 1 > cash Flow > cash From Investing
-486000
Annuals > 1 > cash Flow > cash From Financing
-6550000
Annuals > 1 > cash Flow > net Change In Cash
-75681000
Annuals > 1 > ratios > PE
-2.778720638525301
Annuals > 1 > ratios > PB
0.5532521054389442
Annuals > 1 > ratios > ROE
-207.46734732668966
Annuals > 1 > ratios > ROA
-125.40458917375177
Annuals > 1 > ratios > FCF
-69106000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
1847000
Annuals > 2 > income Statement > gross Profit
-1847000
Annuals > 2 > income Statement > operating Expenses
89149000
Annuals > 2 > income Statement > operating Income
-89149000
Annuals > 2 > income Statement > interest Expense
927000
Annuals > 2 > income Statement > pretax Income
-88222000
Annuals > 2 > income Statement > net Income
-87295000
Annuals > 2 > income Statement > eps
-3.186869258994395
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
27392087
Annuals > 2 > income Statement > income Tax Expense
-927000
Annuals > 2 > income Statement > EBITDA
-87302000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
927000
Annuals > 2 > balance Sheet > cash
120385000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
267000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
124496000
Annuals > 2 > balance Sheet > property Plant Equipment
12840000
Annuals > 2 > balance Sheet > total Assets
139165000
Annuals > 2 > balance Sheet > payables
3125000
Annuals > 2 > balance Sheet > short Term Debt
7585000
Annuals > 2 > balance Sheet > long Term Debt
3165000
Annuals > 2 > balance Sheet > total Liabilities
33518000
Annuals > 2 > balance Sheet > equity
105647000
Annuals > 2 > cash Flow > net Income
-88222000
Annuals > 2 > cash Flow > depreciation
1847000
Annuals > 2 > cash Flow > change In Working Capital
2004000
Annuals > 2 > cash Flow > cash From Operations
-75723000
Annuals > 2 > cash Flow > capital Expenditures
1867000
Annuals > 2 > cash Flow > cash From Investing
-1867000
Annuals > 2 > cash Flow > cash From Financing
-69000
Annuals > 2 > cash Flow > net Change In Cash
-77659000
Annuals > 2 > ratios > PE
-3.186869258994395
Annuals > 2 > ratios > PB
0.1921260089448825
Annuals > 2 > ratios > ROE
-82.62894355731824
Annuals > 2 > ratios > ROA
-62.72769733769267
Annuals > 2 > ratios > FCF
-77590000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1499000
Annuals > 3 > income Statement > gross Profit
-1499000
Annuals > 3 > income Statement > operating Expenses
75044000
Annuals > 3 > income Statement > operating Income
-75044000
Annuals > 3 > income Statement > interest Expense
756000
Annuals > 3 > income Statement > pretax Income
-75800000
Annuals > 3 > income Statement > net Income
-74301000
Annuals > 3 > income Statement > eps
-2.7158411272599343
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
27358375
Annuals > 3 > income Statement > income Tax Expense
-1499000
Annuals > 3 > income Statement > EBITDA
-73545000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-756000
Annuals > 3 > balance Sheet > cash
198053000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
393000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
202517000
Annuals > 3 > balance Sheet > property Plant Equipment
13900000
Annuals > 3 > balance Sheet > total Assets
221599000
Annuals > 3 > balance Sheet > payables
3144000
Annuals > 3 > balance Sheet > short Term Debt
883000
Annuals > 3 > balance Sheet > long Term Debt
9628000
Annuals > 3 > balance Sheet > total Liabilities
36170000
Annuals > 3 > balance Sheet > equity
185429000
Annuals > 3 > cash Flow > net Income
-75800000
Annuals > 3 > cash Flow > depreciation
1499000
Annuals > 3 > cash Flow > change In Working Capital
-11803000
Annuals > 3 > cash Flow > cash From Operations
-80751000
Annuals > 3 > cash Flow > capital Expenditures
1100000
Annuals > 3 > cash Flow > cash From Investing
-1100000
Annuals > 3 > cash Flow > cash From Financing
260668000
Annuals > 3 > cash Flow > net Change In Cash
178817000
Annuals > 3 > ratios > PE
-2.7158411272599343
Annuals > 3 > ratios > PB
0.10932786066365024
Annuals > 3 > ratios > ROE
-40.069784122224675
Annuals > 3 > ratios > ROA
-33.5294834362971
Annuals > 3 > ratios > FCF
-81851000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.11302028219071222
Valuation > metrics > PB
-12.1249151915874
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
201.19825818406426
Profitability > metrics > ROA
-13.125256066210541
Profitability > metrics > Net Margin
-0.854243102905696
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-5.673529411764706
Risk > final Score
7
Risk > verdict
High
Liquidity > metrics > Current Ratio
34.44046627810158
Liquidity > metrics > Quick Ratio
34.44046627810158
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
32.45007670990654
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-25
Prev Risks > 1
-617
Prev Risks > 2
-333
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:26:51.852Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-04
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.1
Earnings History > 0 > eps Difference
0.1
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-13
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.11
Earnings History > 1 > eps Estimate
-0.05
Earnings History > 1 > eps Difference
-0.06
Earnings History > 1 > surprise Percent
-120
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-14
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.16
Earnings History > 2 > eps Estimate
-0.1
Earnings History > 2 > eps Difference
-0.06
Earnings History > 2 > surprise Percent
-60
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-06-13
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.18
Earnings History > 3 > eps Estimate
-0.11
Earnings History > 3 > eps Difference
-0.07
Earnings History > 3 > surprise Percent
-63.6364
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-11
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.2
Earnings History > 4 > eps Estimate
-0.2567
Earnings History > 4 > eps Difference
0.0567
Earnings History > 4 > surprise Percent
22.088
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-09
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.22
Earnings History > 5 > eps Estimate
-0.25
Earnings History > 5 > eps Difference
0.03
Earnings History > 5 > surprise Percent
12
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-08
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.24
Earnings History > 6 > eps Estimate
-0.23
Earnings History > 6 > eps Difference
-0.01
Earnings History > 6 > surprise Percent
-4.3478
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-14
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.62
Earnings History > 7 > eps Estimate
-0.11
Earnings History > 7 > eps Difference
-0.51
Earnings History > 7 > surprise Percent
-463.6364
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-07
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.64
Earnings History > 8 > eps Estimate
-0.64
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-09
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.61
Earnings History > 9 > eps Estimate
-0.81
Earnings History > 9 > eps Difference
0.2
Earnings History > 9 > surprise Percent
24.6914
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-14
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.7
Earnings History > 10 > eps Estimate
-0.87
Earnings History > 10 > eps Difference
0.17
Earnings History > 10 > surprise Percent
19.5402
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-09
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.83
Earnings History > 11 > eps Estimate
-0.89
Earnings History > 11 > eps Difference
0.06
Earnings History > 11 > surprise Percent
6.7416
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-02
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.82
Earnings History > 12 > eps Estimate
-0.78
Earnings History > 12 > eps Difference
-0.04
Earnings History > 12 > surprise Percent
-5.1282
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-09
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.72
Earnings History > 13 > eps Estimate
-0.88
Earnings History > 13 > eps Difference
0.16
Earnings History > 13 > surprise Percent
18.1818
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-09
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.9
Earnings History > 14 > eps Estimate
-0.78
Earnings History > 14 > eps Difference
-0.12
Earnings History > 14 > surprise Percent
-15.3846
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-12
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.78
Earnings History > 15 > eps Estimate
-0.93
Earnings History > 15 > eps Difference
0.15
Earnings History > 15 > surprise Percent
16.129
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-01
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.98
Earnings History > 16 > eps Estimate
-1.17
Earnings History > 16 > eps Difference
0.19
Earnings History > 16 > surprise Percent
16.2393
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-12-02
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-21.27
Earnings History > 17 > eps Estimate
-1.6
Earnings History > 17 > eps Difference
-19.67
Earnings History > 17 > surprise Percent
-1229.375
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-09-01
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-2.28
Earnings History > 18 > eps Estimate
-1.92
Earnings History > 18 > eps Difference
-0.36
Earnings History > 18 > surprise Percent
-18.75
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-24
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.63
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.63
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-23.5307
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-23.5307
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-12-31
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-27.9266
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-27.9266
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-09-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-27.9266
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-27.9266
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-06-30
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-27.9838
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-27.9838
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-31
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-19.8334
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-19.8334
Earnings History > 24 > surprise Percent
-
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company's checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$2
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 31.08% of the total shares of Xilio Development Inc
1.
Bain Capital Life Sciences Investors, LLC(8.8115%)
since
2025/06/30
2.
Merck & Co Inc(2.8629%)
since
2025/06/30
3.
Takeda Pharmaceutical Co Ltd(2.8462%)
since
2025/06/30
4.
Morgan Stanley - Brokerage Accounts(2.7868%)
since
2025/06/30
5.
Ghisallo Capital Management LLC(2.572%)
since
2025/06/30
6.
Vanguard Group Inc(2.2209%)
since
2025/06/30
7.
Vanguard Total Stock Mkt Idx Inv(1.3964%)
since
2025/07/31
8.
AJU IB Investment Co Ltd(1.2884%)
since
2025/06/30
9.
FMR Inc(0.9875%)
since
2025/06/30
10.
Geode Capital Management, LLC(0.7132%)
since
2025/06/30
11.
Vanguard Institutional Extnd Mkt Idx Tr(0.5728%)
since
2025/07/31
12.
Trustees Of Columbia University In The City Of New York(0.4817%)
since
2025/06/30
13.
UBS Group AG(0.463%)
since
2025/06/30
14.
Squarepoint Ops LLC(0.4543%)
since
2025/06/30
15.
Balyasny Asset Management LLC(0.3837%)
since
2025/06/30
16.
Fidelity Extended Market Index(0.3594%)
since
2025/07/31
17.
Renaissance Technologies Corp(0.3168%)
since
2025/06/30
18.
Honkamp Krueger Financial Services Inc(0.2746%)
since
2025/06/30
19.
Two Sigma Investments LLC(0.1506%)
since
2025/06/30
20.
Northern Trust Corp(0.1285%)
since
2025/06/30
21.
Fidelity Total Market Index(0.1227%)
since
2025/07/31
22.
Bridgeway Capital Management, LLC(0.1082%)
since
2025/06/30
23.
Bridgeway Ultra-Small Company Market(0.1082%)
since
2025/06/30
24.
Fidelity Series Total Market Index(0.0966%)
since
2025/07/31
25.
State Street Corp(0.0837%)
since
2025/06/30
26.
XTX Topco Ltd(0.067%)
since
2025/06/30
27.
NT Ext Equity Mkt Idx Fd - NL(0.067%)
since
2025/06/30
28.
Spartan Extended Market Index Pool F(0.0664%)
since
2025/07/31
29.
NT Ext Equity Mkt Idx Fd - L(0.0598%)
since
2025/06/30
30.
Northern Trust Extended Eq Market Idx(0.0598%)
since
2025/06/30
31.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.052%)
since
2025/06/30
32.
Spartan Total Market Index Pool G(0.0404%)
since
2025/07/31
33.
Fidelity Nasdaq Composite Index(0.0276%)
since
2025/07/31
34.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0169%)
since
2025/06/30
35.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0142%)
since
2024/12/31
36.
State St US Extended Mkt Indx NL Cl C(0.0062%)
since
2025/08/31
37.
Vanguard U.S. Eq Idx £ Acc(0.0057%)
since
2025/07/31
38.
SSgA U.S. Total Market Index Strategy(0.0026%)
since
2025/03/31
39.
Northern Trust Wilshire 5000(0.0017%)
since
2025/06/30
40.
State St US Ttl Mkt Indx NL Cl A(0.0017%)
since
2025/08/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.1
Date
2025-09-30
EPS Actual
-0.11
EPS Estimate
-0.05
EPS Difference
-0.06
Surprise Percent
-120%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.